DES exposure in utero linked to earlier menopause

Article

Women who were exposed in utero to diethylstilbestrol (DES) have an increased chance of early menopause, according to a study in the Oct. 1 issue of the American Journal of Epidemiology.

Women who were exposed in utero to diethylstilbestrol (DES) have an increased chance of early menopause, according to a study in the Oct. 1 issue of the American Journal of Epidemiology.

Elizabeth E. Hatch, PhD, of Boston University School of Public Health, and colleagues conducted a study of 4,210 DES-exposed women and 1,829 non-exposed controls. They found that those in the former group were 50% more likely to experience earlier menopause compared with their non-exposed counterparts.

The effect was dose-dependent. Among those exposed to more than 10,000 mg, there was a more than twofold risk. The most affected were the daughters of women in the Dieckmann cohort who participated in a clinical trial of DES in the early 1950s.

Hatch EE, Triosi R, Wise LA, et al. Age at natural menopause in women exposed to diethylstilbestrol in utero. Am J Epidemol. 2006;164:682-688.

Related Videos
Navigating menopause care: Expert insights from ACOG 2024 | Image Credit: mayo.edu.
raanan meyer, md
New data shows elinzanetant's efficacy in treating menopausal symptoms | Image Credit: uvahealth.com
Navigating vasomotor symptoms in breast cancer patients | Image Credit: menopausefoundationcanada.ca.
Fertility counseling for oncology patients | Image Credit: allhealthtv.com
Learning what women prefer in STI preventive care
Related Content
© 2024 MJH Life Sciences

All rights reserved.